Treatment of pediatric and adolescent migraine

Pediatric Annals

Volumn 39, Issue 7, 2010, Pages 416-423

  Hershey, Andrew D ^a,b   Kabbouche, Marielle A ^a,b   Powers, Scott W ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; CYPROHEPTADINE; FLUNARIZINE; FROVATRIPTAN; IBUPROFEN; KETOROLAC; METOCLOPRAMIDE; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NORTRIPTYLINE; PARACETAMOL; PLACEBO; PROCHLORPERAZINE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN SUCCINATE; TOPIRAMATE; TREXIMET; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; TRACE ELEMENT; UBIQUINONE;

CLINICAL EXAMINATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HOSPITAL PATIENT; HUMAN; MIGRAINE; REVIEW; ADOLESCENT; CHILD; DIET SUPPLEMENTATION; MIGRAINE DISORDERS; PSYCHOPHYSIOLOGY;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIOFEEDBACK, PSYCHOLOGY; CHILD; DIETARY SUPPLEMENTS; HISTAMINE ANTAGONISTS; HUMANS; MICRONUTRIENTS; MIGRAINE DISORDERS; SEROTONIN UPTAKE INHIBITORS; UBIQUINONE;

EID: 77955618377     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20100623-06     Document Type: Review

References (50)

1. Matchar DB, Harpole L, Samsa GP, et al. The headache management trial: a randomized study of coordinated care. Headache. 2008;48(9):1294-1310.
2. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache. 1989;29(8):507-509. (Pubitemid 20318930)
3. Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992;12(3):169-171; discussion 128.
4. Pearce I, Frank GJ, Pearce JM. Ibuprofen compared with paracetamol in migraine. Practitioner. 1983;227(1377):465-467.
5. Pfaffenrath V, Cunin G, Sjonell G, Prendergast S. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache. 1998;38(3):184-190. (Pubitemid 28173759)
6. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache. 1996;36(7):419-422.
7. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106(5):989-997.
8. Kabbouche MA, Vockell AL, LeCates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4):E62.
9. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5):541-546.
10. Larkin G. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1999;6(6):668-670. (Pubitemid 29275246)
11. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256-262.
12. Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med. 1996;156(15): 1725-1728.
13. Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40(9):720-723.
14. Tanen DA, Miller S, French T, Riffenburgh RH. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med. 2003;41(6):847-853.
15. Kabbouche MA, Powers SW, Segers A, et al.Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49(1):106-109.
16. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215-2224.
17. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000;40(7):539-549.
18. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50(1):109-115.
19. Forsythe WI, Gillies D, Sills MA. Propanolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26(6):737-741. (Pubitemid 15175452)
20. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79(4):593-597. (Pubitemid 17051427)
21. Levinstein B. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of adolescent migraine. Cephalagia. 1991;11:122-123.
22. Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S. Sodium valproate prophylaxis in childhood migraine. Headache. 2002;42(8):819-822. (Pubitemid 35291518)
23. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(10):1304-1312.
24. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology. 1976;26(2):121-127.
25. Sorge F, Barone P, Steardo L, Romano MR. Amitriptyline as a prophylactic for migraine in children. Acta Neurol (Napoli). 1982;4(5):362-367.
26. Hershey AD, Powers SW, Bentti A-L, de-Grauw TJ. Standardized dosing of amitriptyline is highly effective in a pediatric headache center population. Headache. 1999;39:357-358.
27. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia. 1985;5 Suppl 2:145-148.
28. Guidetti V, Moscato D, Ottaviano S, Fiorentino D, Fornara R. Flunarizine and migraine in childhood. An evaluation of endocrine function. Cephalalgia. 1987;7(4):263-266.
29. Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia. 1988;8(1):1-6.
30. Peroutka SJ, Allen GS. The calcium antagonist properties of cyproheptadine: implications for antimigraine action. Neurology. 1984;34(3):304-309.
31. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol. 2007;22(7):829-835. (Pubitemid 47261234)
32. Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009;123(3):924-934.
33. Apostol G, Lewis DW, Laforet GA, et al. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, longterm open-label safety study. Headache. 2009;49(1):45-53.
34. Apostol G, Pakalnis A, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an openlabel extension trial in adolescents. Headache. 2009;49(1):36-44.
35. Unalp A, Uran N, Oztürk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol. 2008 Dec;23(12):1377-1381.
36. Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47(1):73-80.
37. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005;45(3):196-203. (Pubitemid 40393207)
38. Hershey AD, Powers SW, Winner P, Kabbouche MA. Pediatric Headaches in Clinical Practice. Wiley-Blackwell, 2009.
39. Crawford MJ, Ernst MM, Hershey AD, Powers SW. Management of Headache in Children and Adolescents. In: Penzien DB, Rains JC, Lipton RB, Maizels M, eds. Assessment and Management of Headache: A Psychobiological Perspective. Washington, DC: American Psychological Association Books, 2009.
40. Ernst MM, Powers SW. Nonpharmacologic Treatment of Headache: Hidden Opportunities. In: Winner P, Lewis DW, Rothner AD, eds. Headache in Children and Adolescents. 2nd ed. Hamilton, Ontario: BC Decker, 2008: 255-282.
41. Powers SW, Hershey AD. Biofeedback for Childhood migraine. In: Maria BL, ed. Current Management in Child Neurology. 3rd Edition. New York, NY: BC Decker, 2005: 67-70.
42. Andrasik F, Powers SW, McGrath PJ. Methodological considerations in research with special populations: children and adolescents. Headache. 2005;45(5):520-525.
43. Powers SW, Andrasik F. Biobehavioral treatment, disability, and psychological effects of pediatric headache. Pediatr Ann. 2005;34(6):461-465.
44. Kabbouche MA, Powers SW, Vockell AL, et al. Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years. Headache. 2005;45(10):1298-1303.
45. Hershey A, Powers S, Winner P, Kabbouche M. Pediatric Headaches in Clinical Practice. West Sussex, UK: John Wiley & Sons, Ltd. 2009.
46. Hershey AD, Winner P, Kabbouche MA, et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache. 2005;45(10):1288-1297.
47. Winner P, Powers SW, Kabbouche MA, Hershey AD. Diagnosing and managing headache in children. Curr Treat Options Neurol. 2007;9(1):3-13.
48. Lynch-Jordan AM, Kashikar-Zuck S, Crosby LE, et al. Applying quality improvement methods to implement a measurement system for chronic pain-related disability. J Pediatr Psychol. 2010;35(1):32-41.
49. Eccleston C, Palermo TM, Williams AC, Lewandowski A, Morley S. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2009;(2):CD003968.
50. Palermo TM, Eccleston C, Lewandowski AS, Williams AC, Morley S. Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review. Pain. 2010;148(3):387-397.